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Peptide Hydrogels—A Tissue Engineering Strategy  
for the Prevention of Oesophageal Strictures
Deepak Kumar, Victoria L. Workman, Marie O’Brien, Jane McLaren, Lisa White, 
Krish Ragunath, Felicity Rose, Alberto Saiani, and Julie E. Gough*
Endoscopic treatment of Barrett’s oesophagus often leads to further damage of 
healthy tissue causing fibrotic tissue formation termed as strictures. This study 
shows that synthetic, self-assembling peptide hydrogels (PeptiGelDesign)  
support the activity and function of primary oesophageal cells, leading to 
epithelialization and stratification during in vitro 3D co-culture. Following 
buffering in culture media, rat oesophageal stromal fibroblasts (rOSFs) are 
incorporated into a library of peptide hydrogels, whereas mouse oesopha-
geal epithelial cells (mOECs) are seeded on the surface. Optimal hydrogels 
(PGD-AlphaProC and PGD-CGD2) support mOEC viability (>95%), typical 
cell morphology (cobblestone-like), and slower migration over a shorter dis-
tance compared to a collagen control, at 48 h. Positive expression of typical 
epithelial markers (ZO-1 and cytokeratins) is detected using immunocyto-
chemistry at day 3 in culture. Furthermore, optimal hydrogels are identified 
which support rOSF viability (>95%) with homogeneous distribution when 
incorporated into the hydrogels and also promote the secretion of collagen 
type I detected using an enzyme linked immunosorbent assay (ELISA), at 
day 7. A 3D co-culture model using optimal hydrogels for both cell types 
supports a stratified epithelial layer (expressing involucrin and AE1/AE3 
markers). Findings from this study could lead to the use of peptide hydro-
gels as a minimally invasive endoscopic therapy to manage oesophageal 
strictures.
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1. Introduction
Barrett’s oesophagus is a precancerous 
condition affecting the lower oesoph-
agus. Metaplastic changes occur in the 
epithelium resulting in the presence 
of abnormal cells. Specifically, strati-
fied squamous epithelium is replaced by 
columnar epithelium with the presence of 
mucous-producing goblet cells. The main 
contributing factors are thought to be 
directly related to patients suffering from 
gastro-oesophageal reflux disease (GORD), 
where repeated exposure of acid and bile 
salts from the stomach elicits molecular 
changes, DNA damage, mutations, and 
metaplastic changes.[1] Barrett’s oesoph-
agus is generally left untreated although 
the risk of progression to oesophageal 
cancer is higher than with patients without 
Barrett’s. Oesophageal cancer is reported 
to be on the rise in the western world, 
being the eighth most common cancer in 
the world and the highest cause of cancer 
amongst Caucasian men (UK and USA).[2] 
An estimated 52 000 cases (adenocarci-
nomas) and 398 000 cases (squamous cell 
carcinoma) occur in 1 year, worldwide.[3]
Current treatment options for early oesophageal cancer 
includes endoscopic mucosal resection (EMR) and thermal/
radio ablation therapy, both of which are generally considered 
safe, are used widely, are successful in removing abnormal 
cells and thus decreasing the risk of cancer.[4,5] However, due 
to additional damage to adjacent healthy tissue, in some cases 
this elicits inflammatory responses and uncontrolled fibrosis, 
which could cause subsequent stricture formation (narrowing 
of the oesophagus). Postoperative stricture incidences are 
extremely high with a 70–80% risk of occurrence after cir-
cumferential EMR.[6,7] Current strategies for stricture therapy 
involve the use of endoscopic balloon dilation. However, asso-
ciated complications include perforation, bleeding, and bacte-
raemia.[8] Alternative intervention is required to help improve 
current therapies, which would reduce the chances of stric-
ture formation, improve patient outcomes, reduce morbidity, 
reduce patient revisits, and decrease healthcare systems’ costs 
through reducing repeated dilation therapies and the use of 
dilators and stents.[5,9]
Emerging, alternative strategies for stricture management 
and elimination involve tissue engineering therapies through 
the use of biomaterials. Although a relatively unexplored area, 
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the leading contributor for the development of biomaterial-
based strategies for oesophageal tissue engineering and/or 
stricture management is the Badylak Laboratory. Decellularized 
xenograft extracellular matrix (ECM, derived from porcine 
small intestine submucosa (SIS) and urinary bladder mucosa) 
scaffolds have been developed in the form of tubular constructs 
in order to permit complete tissue regeneration.[6,10–12] Pre-
clinical studies have demonstrated successful endoscopic sur-
gery to place these tubular constructs over the damaged site 
in canine models. Observations revealed oesophageal mucosal 
remodeling with complete re-epithelialization and no stric-
ture formation after 8 weeks.[6,10–12] SIS ECM scaffolds have 
also been implanted into five human patients. In this clinical 
study, ECM scaffolds were retained in place using an Ultraflex 
stent, which was removed between 9 and 18 d after implanta-
tion. Results indicated minimal stricture formation and nearly 
complete mature oesophageal squamous epithelialization by 
4 months.[12]
More recent developments have included the use of 
hydrogels, which have already demonstrated promise for 
a variety of regenerative medicine and tissue engineering 
applications. However, they have only recently been explored 
for gastrointestinal (GI) tract applications, and in particular, 
the management of oesophageal strictures. Hydrogels have 
many advantages over decellularized tubular scaffolds, 
including injectability, use of minimally invasive procedures, 
capacity for repeat administrations, fine-tuned mechanical 
properties, ability to fill an irregularly shaped space, and bio-
activity to mimic native tissue ECM.[13] For these reasons, 
decellularized ECM hydrogels have been developed, which 
may also provide an opportunity for stricture management 
in the future.
The management of oesophageal strictures using hydro-
gels is a relatively unexplored area, although a few studies 
have been performed recently. For example, a steroid-loaded 
hydrogel (Endolubri jelly) has been sprayed endoscopically 
into 20 patients as a combined therapy with balloon dilation. 
Early results are promising where a complete squamous epithe-
lium without stenosis has been witnessed after 3 months.[14,15] 
Other advancements include the use of Food and Drug Admin-
istration (FDA)-approved hydrogels for early treatment and 
improved prognosis of Barrett’s oesophagus with a focus on 
the lower oesophageal sphincter (LOS; which when weakened 
can permit GORD to develop in patients). In one study, a range 
of mucoadhesive hydrogels (Polaxamer 407, cross-linked poly-
acrylic acid, hydroxypropylmethylcellulose, sodium carboxym-
ethylcellulose, and chitosan) were used as a transport material 
for the topical delivery of the optical imaging agent hexylami-
nolevulinate (HAL) into an ex vivo rat model and four, healthy 
human males. Chitosan was revealed to be the best hydrogel 
for oesophageal adhesion in vitro and in vivo. Furthermore, in 
vitro release profiles from chitosan loaded with 40 × 10−3 m of 
HAL demonstrated that after a residence time of 10 min on 
the oesophageal wall, the amount of HAL delivered to the 
epithelium was sufficient to permit fluorescence diagnosis 
of Barrett’s oesophagus. In vivo studies demonstrated that 
increasing the concentration of chitosan (Protasan) from 1.5% 
to 1.7% increased adhesivity and the fluorescence signal, with 
a full thickness layer coating on the mucosa.[16] The remit of 
application was entirely focused at improving prognosis. How-
ever, a study by Johnson et al.[17] focused on the improvement 
of the LOS. Here, a nonresorbable polymer (ethylene vinyl 
alcohol) was injected into the LOS using a sclerotherapy-type 
needle. During injection, the polymer is a nonviscous liquid, 
which solidifies rapidly in situ. This medical device (Enteryx) 
had been made available commercially; however, recent reports 
of patient injury and death as a result of the device led to the 
FDA removing it from the market.[17] Alternative types of 
hydrogel that have recently emerged with promising results are 
decellularized ECM hydrogels (derived from porcine dermal 
and urinary bladder matrix (UBM)). After in vivo implanta-
tion in a rat abdominal wall defect model, both hydrogels had 
degraded by 35 d, and UBM hydrogels were found to support 
greater amounts of myogenesis compared to dermal hydro-
gels.[13] Decellularized hydrogels are progressing toward clinical 
trials and are currently being investigated for oesophageal stric-
tures to facilitate repair and reconstruction.
Alternatives to hydrogels made of ECM/biological materials 
are those made using de novo designed materials. In the past 
decade, great interest has been shown in the development and 
use of synthetic, self-assembling peptide hydrogels. A variety of 
designs of short peptides have been presented that self-assemble 
into water-swollen networks (hydrogels) above a critical gelation 
concentration (CGC).[18] Zhang and colleagues devised a family 
of amphipathic self-assembling peptides based on the alterna-
tion of hydrophilic and hydrophobic residues. These peptides 
are able to self-assemble into β-sheet-rich nanofibrillar struc-
tures (fibers of 3 nm and bundles of 10–50 nm[19]) that, above 
the CGC entangle and/or associate with form hydrogels.[19] The 
propensity of these peptides to self-assemble and the nature 
of the nano-structures and overall properties of the hydrogel 
thus formed are dependent on several factors. These include 
the amino acid sequence, the starting peptide concentration, 
and the pH, and type of electrolyte in the medium.[20] Peptide 
hydrogels are now commercially available from several com-
panies, including Puramatrix (Corning), HydroMatrix (Sigma), 
Biogelx, and more recently PGD-HydroGels (PeptiGelDesign).
There are several advantages in using synthetic, self-
assembling peptide hydrogels including low cost, consistent, 
controllable manufacturing, the fact that amino acids can be 
easily metabolized by enzymes in vivo making the gels highly 
biocompatible,[21] and deliverable endoscopically via spraying 
or injection.[22] A diverse range of properties are made avail-
able through changing both the amino acids present and their 
order within the peptide sequence. The presence of charged 
amino acids allows variation in both net charge and charge 
distribution. Tailored release properties, degradation rates, and 
mechanical properties are all possible using this system, which 
is difficult to achieve with natural polymers.[23]
This study proposes the use of self-assembling peptide hydro-
gels for a novel application to treat and/or manage strictures 
caused by ER for the removal of metaplastic cells in Barrett’s 
oesophagus. It can be anticipated that after delivery of acel-
lular self-assembling peptide hydrogels to the injured area, cells 
from healthy adjacent tissue would be able to migrate, produce 
essential matrix proteins, and permit tissue regeneration. The 
ability to deliver the hydrogel endosocopically is feasible due to 
the shear-thinning and self-assembling properties of these 
Adv. Funct. Mater. 2017, 27, 1702424
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hydrogels.[24] Once the hydrogel is delivered to the injury site, 
it can be anticipated that host fibroblasts and epithelial cells 
from adjacent healthy tissue would migrate into the hydrogel, 
permit re-epithelialization[25] and production of matrix, and 
permit normal function, which is to act as a protective, semi-
permeable barrier.[26,27] Rapid restitution of the mucosal barrier 
would result in a reduced inflammatory response resulting in 
subsequent modulation of fibrosis.[15] Overall, neo-tissue matrix 
production and remodeling would occur with the desired native 
tissue-type matrix composition and mechanical properties.
In order to move toward this ultimate translational goal, 
initial studies were undertaken in vitro, to understand tissue-
specific (stromal fibroblasts and oesophageal epithelial) cell 
response to a library of synthetic peptide hydrogels. As different 
cells require unique extracellular matrix conditions,[28] we spec-
ulated that each cell type would require a distinct gel property. 
Uniquely, PeptiGelDesign can provide a family of related pep-
tide hydrogels, each with particular combinations of charge and 
mechanical properties. Use of the panel allowed us to evaluate 
oesophageal cell response and characterization of cell function 
through morphology, viability, migration, and typical marker 
expression in order to identify optimal hydrogels for each cell 
type. Furthermore, this study is the first to develop a 3D co- 
culture, composite model using self-assembling peptide hydro-
gels in order to demonstrate the multilayer and multicellular 
nature of oesophageal submucosa. Again, the unique properties 
of this hydrogel system allowed combinations of gels to be lay-
ered, providing distinct conditions suitable to support each cell 
type. This study provides the initial steps to be taken forward for 
using synthetic peptide hydrogels in oesophageal stricture man-
agement and potentially for oesophageal tissue engineering.
2. Results
2.1. Rheological Assessment of Peptide Hydrogels
The stiffness of peptide hydrogels was assessed after buffering 
in media for 24 h at 37 °C. The initial pH of each hydrogel was 
different (Table 1) and therefore the buffering step in media 
was critical to allow diffusion of nutrients and molecules 
into the gels as well as neutralize the pH in order to permit 
a cell-friendly environment. Statistical analysis revealed that 
PGD-Alpha1, PGD-Alpha2, PGD-AlphaProC, and PGD-CGD2 
hydrogels were significantly stiffer (G′) compared to PGD-Alp-
haProB and PGD-C2 hydrogels (p < 0.001; Table 1).
2.2. Mouse Oesophageal Epithelial Cell (mOEC) Response  
to Peptide Hydrogels in 2D Culture
mOECs were cultured on top of peptide hydrogels for 3 d, sub-
merged in media (Figure 1A). Viability assessment using the 
Live/Dead assay revealed that mOECs responded differently 
depending on which peptide hydrogel surface they were cul-
tured on. However, after 3 d of culture, mOECs appeared viable 
on all peptide hydrogels as shown in Figure 1B. Obvious effects 
on mOEC morphology and on ability to form an epithelial sheet 
were witnessed as a response to the type of peptide hydrogel 
surface. Observations revealed that PGD-Alpha1, PGD-Alp-
haProC, and PGD-CGD2 supported typical mOEC morphology 
and epithelial sheet formation, whereas on PGD-Alpha2, PGD-
AlphaProB, and PGD-C2 hydrogels, mOECs appeared to clump 
together and the epithelial sheet was not as obvious (Figure 1B). 
Using an ImageJ plug-in Live/Dead, staining images were used 
to semiquantify epithelial cell coverage. These data further reaf-
firmed that PGD-Alpha1, PGD-AlphaProC, and PGD-CGD2 
supported the greatest epithelial sheet coverage with 81%, 
77%, and 65% mOEC coverage on respective peptide hydro-
gels (Figure 1C). Metabolic activity and proliferation activity 
of mOECs cultured on top of peptide hydrogels were assessed 
via the alamarBlue assay. All peptide hydrogels including the 
control (gelatin-coated tissue culture plastic (TCP), as recom-
mended by manufacturers,;see the “xperimental Section” sup-
ported an increase in metabolic activity and proliferation from 
day 1 to day 3. After 3 d of mOEC culture on top of the peptides, 
cells cultured on PGD-Alpha1, PGD-CGD2, PGD-AlphaProB, 
and PGD-C2 displayed similar metabolic activity to the control 
(gelatin-coated TCP) with insignificant differences (Figure 1D). 
However, despite supporting similar metabolic activity, hydro-
gels PGD-Alpha2, PGD-AlphaProB, and PGD-C2 did not sup-
port the formation of an intact epithelial cell sheet (Figure 1B).
Optimal peptide hydrogels (PGD-Alpha1, PGD-AlphaProC, 
and PGD-CGD2) identified from the above data were further 
investigated to characterize the expression of typical epithe-
lial markers by mOECs. ZO-1 staining in mOECs cultured on 
optimal peptide hydrogels at day 3 was witnessed, with similar 
expression to the gelatin control (culture protocol suggested 
by manufacturer for standard in vitro culture of mOECs), 
as shown in Figure 2. Positive expression of a multipanel of 
cytokeratins secreted by mOECs was also observed when cul-
tured on optimal peptide hydrogels at day 3. Similar expression 
patterns were witnessed to the control, as shown in Figure 2, 
further re-affirming similar mOEC behavior. PGD-AlphaProC 
and PGD-CGD2 hydrogels were taken forward to a migration 
assay as these hydrogels supported better expression of ZO-1 
and cytokeratins compared to PGD-Alpha1.
2.3. Migration Activity of mOECs Across Peptide  
Hydrogels During 2D Culture
The ability of mOECs to migrate across candidate peptide 
hydrogels was investigated using a ring migration assay[29] 
(Figure 3A) and time-lapse imaging over a 48 h period. ImageJ 
was then used to translate pixels into distance covered. Data 
revealed that migration of mOECs was achieved on both 
Adv. Funct. Mater. 2017, 27, 1702424
Table 1. Mechanical properties and charge density of peptide hydrogels 
supplied by PeptiGelDesign.
Hydrogel Stiffness G′ after media  
conditioning for 24 h [Pa]
Initial pH Charge density
PGD-Alpha1 15 000 ± 5000 3.0–3.5 Neutral
PGD-Alpha2 21 000 ± 1000 4.2–4.8 Low
PGD-AlphaProC 14 000 ± 1300 6.9–7.1 High
PGD-CGD2   5500 ± 1700 6.0–7.0 Low
PGD-AlphaProB 500 ± 80 6.3–6.7 High
PGD-C2 400 ± 10 6.0–6.6 High
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peptide hydrogels (PGD-AlphaProC and PGD-CGD2) and con-
trol (collagen hydrogels) over 48 h. mOEC distance covered was 
significantly greater on collagen hydrogels compared to peptide 
hydrogels at all time points (20, 24, and 48 h), demonstrated 
in Figure 3B. However, a significantly greater distance was cov-
ered on PGD-AlphaProC (364.4 µm) in comparison to PGD-
CGD2 (177.1 µm) at 48 h.
Analysis of migration rate revealed a similar trend to migra-
tion distance (Figure 3C). As anticipated, migration rate was 
significantly faster on collagen hydrogels compared to peptide 
hydrogels at all time points (20, 24, and 48 h). However, a signif-
icantly faster migration rate was witnessed on PGD-AlphaProC 
(17.432 µm h−1) compared to PGD-CGD2 (10.625 µm h−1) 
at 48 h. Both hydrogels were seen to support migration of 
Adv. Funct. Mater. 2017, 27, 1702424
Figure 1. mOEC behavior when cultured on the surface of peptide hydrogels up to day 3. A) Schematic of experimental setup. B) Viability assessment 
using Live/Dead assay at day 3. C) Metabolic activity of mOEC assessment using alamarBlue assay up to day 3. D) Epithelial coverage on surface of 
peptide hydrogels at day 3. Values indicate average viability (D) or average percentage epithelial coverage as determined by image analysis in part (C), 
±SD where n = 3.
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epithelial cells and so, taken with the previously presented data, 
were deemed suitable for culturing mOEC.
2.4. Rat Oesophageal Stromal Fibroblast (rOSF) Response  
to Peptide Hydrogels in 3D Culture
rOSFs were incorporated into a panel of buffered, peptide 
hydrogels and cultured up to 7 and 14 d in media, as depicted in 
Figure 4A. Live/Dead staining revealed that rOSFs incorporated 
into all peptide hydrogels remained viable after 7 and 14 d of 
culture (Figure 4B). Morphological differences in rOSFs were 
also apparent at day 14, depending on which peptide hydro-
gels they were cultured in. rOSFs appeared more fibroblastic 
in PGD-AlphaProC, PGD-C2, and PGD-CGD2 hydrogels, 
whereas in PGD-Alpha2 and PGD-AlphaProB, rOSFs remained 
rounded, at day 14. As expected, rOSFs cultured in collagen 
hydrogels retained their typical fibroblastic-like morphology, 
Adv. Funct. Mater. 2017, 27, 1702424
Figure 2. Characterization of typical epithelial markers. A) ZO-1 marker and B) multipanel of cytokeratins expression by mOECs cultured on the surface 
of optimal peptide hydrogels at day 3. Scale bar = 100 µm.
Figure 3. Determination of the migration activity of mOECs across the surface of optimal peptide hydrogels cultured up to 72 h. A) Schematic of 
experimental setup, B) migration distance, and C) migration rate. Values indicate the average migration distance (µm) or migration rate (µm h−1) and 
±SD where n = 3.
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and more cells were observed to be present on both days 7 and 
14 compared to all peptide hydrogels investigated.
Confocal microscopy was used to determine how homoge-
neously distributed cells were throughout the hydrogel. Stud-
ying the distribution of rOSFs in the peptide hydrogels allowed 
us to establish whether the hydrogel environment supported 
cell growth and migration, or if cells clustered together in an 
attempt to survive. Figure 4C represents the full thickness 
(≈200 µm) view of z-stack Live/Dead images compiled using 
confocal microscopy. As expected, a greater number of rOSFs 
were witnessed in collagen hydrogels at days 7 and 14 in com-
parison to the peptide hydrogels (Figure 4C). rOSFs appeared 
most homogeneously distributed when encapsulated in PGD-
AlphaProB and PGD-C2 (both of which are mechanically 
weaker gels in the panel, Table 1) at both time points, followed 
by collagen hydrogels (Figure 4C). On the contrary, rOSFs 
appeared to cluster together, and heterogeneously distribute 
themselves within PGD-Alpha2 and PGD-AlphaProC (both of 
which are the stiffest gels in the panel, Table 1) at both time 
points (days 7 and 14).
2.5. Immunohistochemistry and Quantification of Collagen  
Type I Using ELISA
Type I collagen secretion into the hydrogels by rOSFs was 
determined via immunohistochemistry. Observations revealed 
a greater number of rOSFs present in PGD-C2 compared 
to PGD-AlphaProC at both time points (days 7 and 14). Fur-
ther to this, greater amounts of type I collagen were present 
Adv. Funct. Mater. 2017, 27, 1702424
Figure 4. The behavior of rOSFs embedded within a panel of peptide hydrogels for 3D culture up to day 14. A) Schematic of experimental set-up. 
B) Assessment of rOSF viability and morphology using Live/Dead assay. C) Assessment of rOSF distribution within the hydrogels using Live/Dead 
assay. Scale bar = 100 µm.
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surrounding individual rOSFs in PGD-C2 compared to PGD-
AlphaProC (Figure 5A).
To further determine and quantify the secretion of type I 
collagen into the hydrogel (PGD-AlphaProC and PGD-C2), col-
lagen was quantified using ELISA in constructs cultured up to 
days 7 and 14. An increase in collagen production from day 7 
to day 14 was witnessed in both hydrogels, PGD-AlphaProC 
(0.007–0.0295 µg mL−1) and PGD-C2 (0.264–0.3884 µg mL−1). 
PGD-C2 supported the highest amount of type I collagen 
production at days 7 and 14 compared to PGD-AlphaProC 
(Figure 5B).
Taking all the data as a whole, PGD-C2 was seen to be the 
best peptide hydrogel at supporting rOSF growth, homo-
geneous distribution and collagen type I secretion. PGD- 
AlphaProC was also chosen for further investigation, as cells 
grown in this peptide hydrogel were seen to be more fibro-
blastic in morphology. We were also interested to determine 
if a single peptide hydrogel may be suitable for growing both 
cell types thus simplifying clinical translation; this was an addi-
tional reason for selecting PGD-AlphaProC.
2.6. Histological Evaluation of the 3D Co-Culture  
Composite Model
Optimal performing peptide hydrogels for 2D culture of epi-
thelial cells (PGD-AlphaProC) and 3D culture of fibroblast cells 
(PGD-C2) were taken forward to produce composite hydrogel 
systems in order to assess 3D co-culture. Alternative systems 
were established, namely, system 1 (PGD-AlphaProC for both 
cell types) and system 2 (PGD-C2 incorporating OSFs; PGD-
AlphaProC with OECs on top), and were cultured up to day 7 
(Figure 6). Histological evaluation using hematoxylin and eosin 
(H&E) staining, for both systems, revealed that a successful, 
uninterrupted layer of mOECs was formed at day 7 with typical 
multicellular layers. Histological staining for specific epithe-
lial markers revealed that there was positive expression of 
AE1/AE3 and involucrin for both systems at day 7 (Figure 6). 
rOSFs were also observed within the bottom hydrogel compo-
nent of both composite systems, where the rOSFs displayed a 
rounded morphology.
3. Discussion
This study is the first to report the response of primary oesoph-
ageal cells (epithelial cells and stromal fibroblasts) to synthetic 
self-assembling peptide hydrogels. A library of peptide hydro-
gels (Table 1) was explored, each displaying unique physical 
characteristics including stiffness and overall net charge. Due 
to the complex nature of this study, it was apparent that an 
available material with easily tailorable mechanical properties 
(a library) would be beneficial to support each cell type. Self-
assembling peptides are infinitely tailorable, and hence were 
the prime candidate for the remit of this study. The rationale 
behind using such peptide hydrogels was to identify a synthetic 
matrix that could support mucosal regeneration as an initial 
step toward the development of a tissue-engineered therapy for 
the management of stricture formation following endoscopic 
treatment for Barrett’s oesophagus.
From this study, it was clear that the behavior (morphology, 
proliferation, and intact epithelial cell sheet formation) of 
mOECs was influenced by the properties of peptide hydrogels 
despite demonstrating similar cell viability across the panel. 
Having a library of various peptide hydrogels allowed the iden-
tification of the optimal gel to be chosen for each cell type 
Adv. Funct. Mater. 2017, 27, 1702424
Figure 5. Characterization of type I collagen production. A) Immunohistological images of type I collagen production by rOSFs cultured in PGD-
AlphaProC and PGD-C2 hydrogels after 7 and 14 d. B) Quantification of type I collagen production by rOSFs cultured in PGD-AlphaProC and PGD-C2 
hydrogels at days 7 and 14. Values indicate mean amount of collagen values ±SD where n = 3 (three replicates in a single experiment). Arrows indicate 
the presence of rOSFs surrounded by deposition of collagen type I within the hydrogels.
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(mOEC and rOSF). Such assays have been performed in studies 
with a similar remit where the necessity of validating tissue-
specific cell behavior and functionality in vitro before moving 
toward in vivo, were specifically highlighted.[25,27] After 3 d of 
mOEC culture on top of buffered peptide hydrogels, the prefer-
ential peptide hydrogels were identified as PGD-AlphaProC and 
PGD-CGD2 as demonstrated by the typical cobblestone-like 
morphology and tight junction formation between cells (ZO-1 
expression), resulting in an epithelial sheet-like formation. 
Positive expression of cytokeratins was also observed. Interest-
ingly, PGD-AlphaProC and PGD-CGD2 were among the stiffest 
hydrogels in the panel ranging between 5.5 and 14 kPa.
In order to represent the mucosa of the oesophagus (which 
can be damaged during oesophageal surgery), primary stromal 
fibroblasts were incorporated and cultured in 3D in buffered 
peptide hydrogels. Again, differences in behavior in terms of 
cell morphology and homogeneous distribution were observed 
and influenced by the properties of the peptide hydrogel. Here, 
the optimal hydrogels were revealed to be PGD-AlphaProC (the 
third stiffest in the panel) and PGD-C2 (weakest in the panel at 
0.4 kPa) based on the ability of the cells to remain viable and to 
adopt a fibroblastic phenotype.
The difference in such cell behavior can be attributed to many 
different material-related aspects. Indeed, each aspect will have 
a combinatorial effect on cell response; however, for clarity, 
each aspect will be discussed in turn. The panel of peptides 
utilized in this study has varying numbers of charged amino 
acids present, thus varying the charge of the assembled hydro-
gels. The overall charge carried on hydrogels can heavily influ-
ence cell adhesion and behavior. Positively charged surfaces are 
known to increase cell attachment and proliferation; as dem-
onstrated by Schneider et al.[23] Negatively charged hydrogels 
have also been shown to increase proliferation of endothelial 
cells[30] and improve cartilage regeneration in vivo,[31] although 
Liu et al.[32] observed decreased fibroblast proliferation on nega-
tively charged hydrogels. These differences in findings about 
which charge cells favor lead us to speculate that certain cells 
prefer a specific charge, be it positive or negative. However, our 
study appears to indicate that the effect of charge is overriding 
the effect of mechanical properties. The mechanical proper-
ties, for example, of PGD-Alpha1 (15 kPa) and PGD-AlphaProC 
(14 kPa) are very similar, whereas the charges are neutral and 
highly positive, respectively. Although the mechanical proper-
ties are very similar, both cell types responded differently to 
these two hydrogels. Neither cell type preferred PGD-Alpha1 
suggesting that they preferred positively charged material over 
neutrally charged. There are undoubtedly synergistic responses 
between mechanical properties, charge, and other factors and 
charge cannot be said to be the only reason cells prefer the gels 
they do.
Variations in mechanical properties of the self-assembled 
hydrogels used in this study can also impact cell response. Dif-
ferential proliferation rates and cell spreading have been widely 
reported within hydrogels of different stiffness, as reviewed 
in Ahearne.[33] Matrix stiffness has also been demonstrated 
to dictate changes in cell phenotype,[28] cytoskeleton,[34] pro-
liferation,[35] and mobility,[36] as well as drive stem cell differ-
entiation toward specific lineages.[28] Growing both cell types 
with the panel of hydrogels with different mechanical prop-
erties revealed that mOECs appeared to prefer stiffer peptide 
hydrogels in comparison to rOSFs, which when encapsulated 
in three dimensions require weak gels for motility. Further 
analysis revealed that there is a fine line in the preferred stiff-
ness (between 5.5 and 14 kPa) of the hydrogels for mOEC 
attachment and expansion. On the softer peptides (PGD- 
AlphaProB and PGD-C2), mOECs were not able to retain a flat 
epithelial sheet and instead detached away from the hydrogel 
indicating weak attachment and interaction of mOECs to the 
surface of these hydrogels. Likewise, on PGD-Alpha2, which 
was the stiffest hydrogel in the panel, cells could not attach. 
Further studies would be required to profile cell surface inte-
grin binding and cytoskeleton behavior to elucidate how 
Adv. Funct. Mater. 2017, 27, 1702424
Figure 6. Histological analysis of 3D co-culture composite systems, cultured up to day 14 at air–liquid interface. Schematic of the two co-culture 
systems (system 1 and system 2) with H&E staining, AE1/AE3 multicytokeratin staining, and involucrin staining. Asterisk indicates the positive 
expression of specific epithelial markers (AE1/AE3 or involucrin), and the arrows are pointing to single rOSFs with surrounding collagen deposition.
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well mOECs anchor/interact with the substrate and whether 
changes in interaction occur as a result in stiffness change.
Hydrogel stiffness also influenced rOSF behavior; in par-
ticular, the homogeneous distribution within the hydrogels 
was enhanced after encapsulation within the softer hydrogels 
(PGD-AlphaProB and PGD-C2). Interestingly, increase in cell 
number appeared to remain similar across the panel of hydro-
gels, as shown visibly in the Live/Dead images from day 7 to 
day 14, which possibly suggests that the hydrogels may have an 
inherent property to modulate fibroblastic proliferation activity. 
However, this property would have to be investigated further. 
Conclusively, it appears that there is a combination of material-
related factors (charge and mechanical properties) that work 
in synergy to influence the effect on cell response—some of 
which are yet to be fully defined and understood.
Additional benefits of these peptide hydrogels are that they 
have a nanofibrillar architectural structure which is similar to 
that of native ECM, and are shear thinning. This property pro-
vides the opportunity to deliver/inject the hydrogel material 
(either in acellular form or as a cell delivery vehicle) in a mini-
mally invasive manner through endoscopy. This delivery would 
require minimal deviation from current oesophageal treat-
ments, which take place endoscopically. Furthermore, the pep-
tide hydrogels that mOECs responded well to (PGD-AlphaProC 
and PGD-CGD2) also possess similar mechanical properties to 
the native human oesophagus tissue interface (5–50 KPa).[37] In 
fact, after media conditioning, the majority of the hydrogels on 
the panel had G′ values above 5 kPa, except PGD-AlphaProB 
and PGD-C2.
As this study was the initial step toward the development 
of a tissue engineering therapy, future investigations would 
be required to elucidate the degradation profile of the optimal 
hydrogels before moving toward in vivo implantation studies. 
These degradation studies would be needed to confirm that the 
gel did not degrade/lose mechanical stiffness within the time 
period required for epithelialization. Through the use of the 
hydrogel we would anticipate promotion of early epitheliali-
zation (in this study epithelial sheet formation was witnessed 
within 7 d on the hydrogels), which would subsequently mini-
mize associated proinflammatory responses thought to be 
critical in the prevention of stricture formation.[6] Further in 
vitro and in vivo studies are required to investigate the ability of 
the hydrogel to modulate inflammatory responses and fibrotic 
tissue formation.
As we demonstrated a positive oesophageal cell response to 
the identified peptide hydrogels in vitro, an alternative strategy 
to cell-loaded hydrogels could be the delivery of an acellular 
peptide hydrogel in vivo. Migration data supported the fact that 
mOECs were able to migrate across the peptide hydrogel sur-
face and permit epithelialization. By replicating this scenario in 
vivo after implantation, we envisage the migration of epithelial 
cells from healthy adjacent tissue on to the peptide hydrogel 
and for the hydrogel to efficiently permit re-epithelialization 
of the oesophagus. In addition, an acellular product presents a 
more feasible route to market, and one with less risks and con-
cerns due to the absence of biological material.
This is the first study that has attempted to replicate the in 
vivo oesophageal mucosa structure (epithelium and stroma, 
which are usually damaged during endoscopic treatment and 
surgery) of the oesophagus in vitro by assessing cell response 
when in 3D co-culture within synthetic peptide hydrogels. 
Other, in vitro 3D co-culture systems do exist; however, these 
are developed using xenogenic material.[26,38] For this investiga-
tion a composite hydrogel system was formulated as the two 
different cell types of interest (mOECs and rOSFs) preferen-
tially grew on different hydrogels. The top layer, which sup-
ported the epithelial layer, was cultured at air–liquid interface 
to mimic the in vivo environment of the oesophageal epithe-
lium. Histological analysis of both composite systems (cultured 
for 7 d) revealed the presence of stromal fibroblasts within the 
bottom layer hydrogel and a distinct, uninterrupted epithelium 
layer on the surface of the top-layered hydrogel. On both com-
posites, #1 and #2, the epithelium consisted of 2–3 layers of 
cells, therefore, indicating epithelium stratification starting to 
take place after 7 d of culture. The number of cell layers can be 
attributed to the cross-talk between stromal fibroblasts and epi-
thelial cells when in co-culture. In a similar study, an organo-
typic model using a mixture of xenogenic material consisting of 
collagen hydrogel and Matrigel with incorporated stromal fibro-
blasts was cultured for 7 d before seeding oesophageal epithe-
lial cells on top and continuing culture up to day 15.[26] Despite 
the contraction of the hydrogel by the stromal fibroblasts, the 
cross-talk between both cell types promoted a stratified epithe-
lium to be formed on top with the positive expression of invo-
lucrin and cytokeratins. In our study the stromal fibroblasts did 
not visually contract the peptide hydrogels but still supported 
the formation of an epithelium within an organotypic (co-cul-
ture) model.
This study highlighted the difference in fibroblast mor-
phology depending on the culture conditions. For example, a 
fibroblastic morphology was witnessed when fibroblasts were 
cultured in 3D whereas under co-culture conditions fibroblasts 
in fact, remained rounded. It is generally accepted that epithe-
lial cells and fibroblasts in the submucosa communicate via 
paracrine signals, which influence cell differentiation, function, 
and proliferation.[27] We hypothesize that this signaling phe-
nomenon may be responsible for the observed differences in 
morphology of fibroblasts.
It is imperative for the biomaterial of choice to promote 
stratified epithelialization as this indicates a thick epithelium 
with appropriate function, such as forming a protective bar-
rier.[39] Only a limited number of studies have attempted to 
understand epithelial cell interaction to appropriate substrates 
in vitro; Beckstead et al.[40] investigated oesophageal epithelial 
behavior on a range of synthetic (polyesters) and natural 
(Alloderm—decellularized skin graft) scaffolds. Alloderm sup-
ported the formation of a 5–6 cell layer epithelium with the 
expression of loricrin (late stage marker for epithelium; similar to 
involucrin) after 18 d in culture. On the other hand, the synthetic 
scaffolds only supported a 2–3 cell layer epithelium which 
lacked overall spatial organization and formed an interrupted 
layer. This lack of epithelialization may have been attributed to 
the pore size, structure, and surface properties of the scaffolds. 
Synthetically produced peptide hydrogels used in the current 
study also supported a 2–3 cell layer epithelium, however, in 
this case, formed a continuous layer within an accelerated time 
period (7 d) and also expressed late stage differentiation marker 
(involucrin). The observed outcomes indicate that the structural 
Adv. Funct. Mater. 2017, 27, 1702424
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and surface properties, as well as the pore size, may be archi-
tecturally suitable for supporting the formation of a functional 
epithelium. Further to this, synthetic peptide hydrogels may 
eradicate the need to pre-coat synthetic scaffolds with ECM pro-
teins such as collagen and fibronectin to support the expansion 
of oesophageal epithelial cells, providing a minimally invasive 
therapy, which is reproducible and could be mass produced.
4. Conclusion
Synthetic peptide hydrogels (PGD-AlphaProC and PGD-CGD2) 
have been identified to support mOEC adhesion, proliferation, 
typical morphology, and epithelial cell sheet formation with pos-
itive expression of typical markers (AE1/AE3 and involucrin). 
Additionally, synthetic peptide hydrogels (PGD-AlphaProC and 
PGD-C2) were identified to support 3D homogeneous distribu-
tion of viable rOSFs. A co-culture model was set up containing 
both cell types (mOECs and rOSFs) demonstrating a multicel-
lular and multilayer hydrogel system. The co-culture system 
successfully supported the formation of a functional, uninter-
rupted epithelial sheet within 7 d of culture. This study has 
highlighted preferential synthetic peptide hydrogels to support 
cytocompatibility to oesophageal cells and is the initial step in 
identifying materials suitable or development of a tissue engi-
neering therapy as a postendoscopic treatment for stricture 
management in Barrett’s oesophagus.
5. Experimental Section
Peptide Hydrogels: A library of synthetic, self-assembling peptide 
hydrogels was purchased from PeptiGelDesign (Cheshire, UK). Each 
hydrogel is different in terms of peptide sequence, stiffness, and overall 
charge that the peptide holds. Peptide hydrogels were sterilized by 
PeptiGelDesign using γ irradiation prior to cell culture. Rheological 
properties of hydrogel samples were measured after conditioning with 
media for 24 h at 37 °C in a humidified CO2 incubator. All rheological 
studies were undertaken using a stress-controlled rheometer (Discovery 
HR2, TA Instruments, Herts, UK) equipped with 20 mm parallel plates. 
In each experiment, 200 µL of sample was loaded onto the stage and 
the upper plate lowered until a 500 µm gap was reached. All readings 
were taken at 37 °C. At least once for each sample, amplitude sweeps 
were performed at a fixed frequency of 1 Hz in the 0.1–10% strain 
range to determine the linear viscoelastic region (LVR) of each sample. 
Frequency sweeps were then performed at 1% strain, within the LVR of 
the samples. Thereafter, measurements of G′ and G″ were recorded at 
0.2% strain and frequency of 1 Hz. All measurements were repeated at 
least three times to ensure reproducibility.
Oesophageal Cell Expansion: Primary mouse oesophageal epithelial 
cells were purchased from CellBiologics (catalog #: C57-6046, USA) 
and cultured as instructed per manufacturers’ protocol. Briefly, flasks 
were pre-coated with 0.2% gelatin (30 min at room temperature (RT)), 
washed twice with phosphate buffered saline (PBS), and seeded with 
OECs. Cells were cultured in epithelial cell medium and supplement 
kit (catalog #M6621-kit; Caltag, UK), which consisted of basal media 
supplemented with 2 × 10−3 m l-glutamine (LG), antibiotic antimycotic 
solution (A&A ; 100 U penicillin, 0.1 µg streptomycin, and 0.25 µg mL−1 
amphotericin), 5% fetal bovine serum (FBS), insulin–transferrin–sodium 
selenite, hydrocortisone, and epidermal growth factor. Media changes 
took place every other day, and cells were passaged at ≈70% confluence 
using trypsin (0.5 g; Sigma, T3924) and reseeded at a split ratio of 1:3.
Primary rat oesophageal stromal fibroblasts were directly isolated 
from Sprague Dawley rat oesophageal stromal tissue donated as waste 
tissue from a different animal study. After sacrifice, oesophagus tissue 
was washed in PBS with A&A (100 U penicillin, 0.1 µg streptomycin, 
and 0.25 µg mL−1 amphotericin) for 5 min, followed by two PBS 
washes. Tissue was treated with dispase I (4 U mL−1; Sigma, Dorset, 
UK) overnight at 4 °C. The following day, oesophagus tissue was cut 
longitudinally and the epithelial layer removed. The remaining stromal 
tissue was cut, diced into small pieces, and treated with sterile filtered 
collagenase type II dissolved in Hanks solution (100 U mL−1; Gibco, UK) 
for 2 h in a water bath at 37 °C. Brief vortexing took place every 20 min. 
Tissue in collagenase II solution was quenched in media consisting 
of Dulbecco’s modified Eagle’s medium (DMEM) high-glucose 
supplemented with 10% FBS, 2 × 10−3 m LG, and A&A (100 U penicillin, 
0.1 µg streptomycin, and 0.25 µg mL−1 amphotericin), and then passed 
through a cell strainer (70 µm pore size). Cell solution was centrifuged 
at 1400 rpm for 3 min, supernatant removed and the fibroblasts (1 × 106 
cells) plated out per T75 flask with the same media used for quenching. 
Cells were incubated at 37 °C, and a media change took place after 48 h 
and approximately every 2 d as necessary thereafter.
Oesophageal Cell Culture with Peptide Hydrogels: Peptide hydrogels 
were pipetted into 24-well ThinCerts (Griener, UK) and pre-equilibrated 
in media, overnight, to pH 7. Media were removed, and cells were 
introduced using the following protocols.
Oesophageal Cell Culture with Peptide Hydrogels—2D Culture of 
OECs: OECs were trypsinized and a cell suspension was prepared at a 
density of 3000 cells mm−2/20 µL. Cell suspension was seeded directly 
on top of hydrogels (100 µL volume) and incubated for 30 min before 
submerging with media by adding to the surrounding areas of the insert 
in the well. Cell–gel constructs were expanded up to day 3 with media 
changes taking place every day. Controls used were gelatin-coated-glass 
coverslips.
Oesophageal Cell Culture with Peptide Hydrogels—3D Culture of OSFs: 
OSFs were trypsinized, and a cell suspension was prepared at a density 
of 200 000 cells/10 µL. Media were removed from buffered hydrogels, 
and cell suspension was injected using a 10 µL pipette tip into the 
hydrogel (150 µL) to give a final seeding density of 200 000 cells/150 µL 
volume of hydrogel. The cells were homogeneously integrated by mixing 
the cell suspension with the hydrogel using a pipette tip. OSF-laden 
hydrogels were incubated for 15 min to allow reassembly of the 
hydrogel network and then immersed in media. Media changes took 
place every 3–4 d and cell–gel constructs were cultured up to days 7 and 
14. Controls used were collagen hydrogels (Rat tail, type I collagen; 
Millipore, UK).
Oesophageal Cell Culture with Peptide Hydrogels—3D Co-Culture: The 
optimal performing peptide hydrogels for 2D culture (PGD-AlphaProC) 
and 3D culture (PGD-C2) were taken forward for this experiment. Two 
systems were investigated: system 1 (PGD-AlphaProC for both cell types) 
and system 2 (PGD-C2 incorporated with OSFs and PGD-AlphaProC 
with OECs on top). OSFs (500 000 cells/10 µL) were incorporated 
into buffered PGD-AlphaProC or PGD-C2 peptide hydrogels, using 
the procedure stated previously. After 5 d of culture, 50 µL of PGD-
AlphaProC was added on top of PGD-AlphaProC (system 1) and PGD-C2 
(system 2). Stromal fibroblast media were added on top to buffer the 
peptide hydrogels for 2 h in the incubator at 37 °C. Media were removed, 
and OECs (3000 cells mm−2/20 µL) were seeded on top of the hydrogels 
and incubated for 2 h to allow attachment. Stromal fibroblast media 
were removed from the top and fresh stromal fibroblast media were 
added around the inserts, allowing the top layer to be cultured at the 
air–liquid interface. Composites were cultured at 37 °C until days 7 and 
14, with media changes taking place every 3–4 d.
OEC Viability Analysis on Peptide Hydrogels: Cell viability with hydrogels 
was investigated using a Live/Dead cell double staining kit (Sigma, Dorset, 
UK). Media were removed from cell–hydrogel samples and controls, 
washed twice with PBS and stained with calcein-AM and propidium 
iodide solution as per manufacturer’s instructions. Briefly, samples were 
immersed in staining solution and incubated at 37 °C for 15–20 min. 
Staining solution was removed from samples, washed twice with PBS and 
imaged with a confocal microscope using 490 nm/515 nm (excitation/
emission) for calcein-AM and 535 nm/617 nm (excitation/emission) for 
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propidium iodide. Semiquantification of epithelial coverage on peptide 
surfaces was calculated using an ImageJ plug-in where Live/Dead 
staining images were used. Briefly, the threshold was adjusted to detect 
the difference between green and black, and then analyzed to quantify 
percentage coverage.
OEC Metabolic and Proliferation Activity on Peptide Hydrogels: 
Metabolic activity of OECs was evaluated using the alamarBlue assay 
(5 × 10−3 m, prepared in PBS; Sigma, Aldrich, UK). Media were removed 
from samples, washed twice in PBS (immersed in PBS for 5 min each 
time), and then incubated in alamarBlue solution at 37 °C for 2 h. 
Absorbance values were taken after 2 h in culture at 570 nm/585 nm 
(excitation/emission) using a BMG LABTECH plate reader. alamarBlue 
solution was removed, and samples were thoroughly washed in PBS and 
cultured in fresh media until the next time point.
Migration Assay: 12 well ThinCerts were coated with 200 µL of 
hydrogel (PGD-AlphaProC, PGD-CGD2 and collagen) and buffered 
in media overnight, inside a 12-well plate. A snipped pipette tip was 
used to act as a cloning ring and a barrier to cell seeding and placed 
centrally on top of the hydrogel. OECs were trypsinized, and a cell 
seeding solution of 60 000 cells/50 µL was prepared. Cell solution 
was seeded on top of the hydrogel around the outer perimeter of the 
barrier. Constructs were carefully incubated at 37 °C for 1 h to allow 
cell attachment to hydrogel. Media were added around the insert and 
samples then incubated overnight. On the following day, the barrier was 
removed, media changed and samples transferred to the JuLi Br & FL 
station microscope (NanoEnTek) in the incubator. Cell migration over 
72 h was monitored using time-lapse imaging. Cell migration rate and 
distance was calculated using ImageJ.[41]
Characterization of Marker Expression of OECs Cultured on Peptide 
Hydrogels: Media were removed from OECs cultured on top of 
hydrogels for 3 d. Hydrogels were washed with PBS and fixed in 10% 
formalin solution (neutral buffered; HT5012, Sigma-Aldrich, UK) at 
RT for 10–15 min. Fixative was removed and hydrogels treated with 
permeabilization/blocking buffer (0.1% Triton X-100, 1% bovine serum 
albumin (BSA), and 1% goat serum, in PBS) for 30 min at RT. Marker 
expression was assessed using the following methods:
Characterization of Marker Expression of OECs Cultured on Peptide 
Hydrogels—ZO-1: Hydrogels were treated with 2.5 µg mL−1 primary 
ZO-1 antibody (rabbit ZO-1 anti-mouse; 61–7300, Invitrogen, UK,) 
diluted in the same blocking buffer for 2 h at RT. Hydrogels were washed 
twice with PBS and treated with a goat anti-rabbit Alexa Fluor 546 
secondary antibody (5 µg mL−1, catalog #: A11010; Invitrogen, UK) for 
45 min at RT. After treatment, hydrogels were washed twice in PBS and 
counterstained with 4′,6-diamidino-2-phenylindole (DAPI) for 10 min at 
RT. Samples were imaged using fluorescence microscopy (Nikon Eclipse 
50i Microscope).
Characterization of Marker Expression of OECs Cultured on Peptide 
Hydrogels—Cytokeratin: Hydrogels were treated with mouse monoclonal 
anti-pan cytokeratins conjugated with fluorescein isothiocyanate (FITC) 
(1:50, catalog #: F3418, Sigma, UK) at 4 °C overnight. On the following 
day, samples were washed twice with PBS and counterstained with DAPI 
for 10 min at RT and imaged using fluorescence microscopy (Nikon 
Eclipse 50i Microscope).
Histological Staining of 3D Co-Cultures: Composites cultured for 7 and 
14 d were fixed in 10% formalin for 1 h and washed twice with PBS. 
Composites were then processed overnight using a VIP 2000 (Vacuum 
Infiltration Processor, Miles Scientific). Samples were embedded in 
Paraplast paraffin wax (Sigma) and sectioned transversely using a Leica 
RM2145 microtome. Samples were sectioned at 5 µm and attached to 
Poly-l-lysine slides (Thermo Scientific).
Histological Staining of 3D Co-Cultures—H&E Staining: Sections were 
de-waxed in xylene for 5 min, followed by re-hydration in descending 
grades of ethanol to water. They were stained with hematoxylin for 5 min 
and “blued” in running water for 5 min. Sections were stained in Eosin 
Y for 2 min followed by three 1 min washes in 95% ethanol. Sections 
were then washed in absolute ethanol ×3 and “cleared” in xylene. 
Sections were then mounted with DPX mountant (Sigma). Samples 
were imaged using a LEICA DMRB fluorescence microscope.
Histological Staining of 3D Co-Cultures—Involucrin and Collagen Type I 
Immunohistochemical Staining: Sections were de-waxed in xylene for 
5 min, followed by rinsing in descending grades of ethanol. They were 
then placed into methanol/H2O2 to block any endogenous peroxidase 
(30 min at RT) and finally washed in distilled water for 5 min. Antigen 
retrieval was performed using citrate pH 6 buffer (incubating at 96 °C, 
for 30 min). Sections were then blocked using R.T.U horse serum 
(10 min at RT). Primary antibody treatment (rabbit involucrin anti-
mouse: 1:1000, overnight at 4 °C; catalog #: Biolegend-924401; 
Biolegend, USA) or (rabbit Collagen I anti-rat: 1:500, overnight at 4 °C; 
catalog #: ab34710; Abcam, UK) was followed by secondary antibody 
treatment with R.T.U ImmPRESS anti-rabbit immunoglobulin G (IgG) 
(catalog #: Vector-MP-7401) for 30 min at RT. Sections were then treated 
with 3,3′-diaminobenzidine (DAB) substrate (Vector) for 5 min and 
counterstained with Nuclear Fast Red (Vector) for 2 min. Sections were 
then de-hydrated to xylene and coverslips mounted with DPX mountant 
(Sigma). Samples were imaged using fluorescence microscopy (Nikon 
Eclipse 50i Microscope).
Histological Staining of 3D Co-Cultures—AE1/AE3 
Immunohistochemistry Staining: Sections were de-waxed in xylene for 
5 min, followed by rinsing in descending grades of ethanol. Sections 
were then placed into methanol/H2O2 to block any endogenous 
peroxidase (30 min at RT) and then washed in distilled water for 
5 min. Antigen retrieval was performed using proteinase K (37 °C, for 
10 min). Sections were then blocked in 2.5% goat serum (10 min at 
RT) followed by staining with primary antibody (mouse-IgG1 AE1/AE3 
anti-rat, 1:20 dilution, overnight at 4 °C; catalog #: Thermo-MA1-82041; 
ThermoFisher, UK). After removal of primary antibody, sections were 
treated with secondary antibody (1:200, biotinylated goat anti-mouse 
IgG, 30 min at RT). Sections were then treated with avidin–biotin 
complex (Vector, UK) for 30 min at RT, washed in PBS for 5 min and 
then treated with DAB substrate (Vector, UK) for 5 min. Sections were 
counterstained with Nuclear Fast Red (Vector, UK) for 2 min, dehydrated 
to xylene and cover-slipped using DPX mountant (Sigma). Samples were 
imaged using fluorescence microscopy (Nikon Eclipse 50i Microscope).
Quantification of Collagen Type I enzyme linked immunosorbent assay 
(ELISA): Media were removed from hydrogels (PGD-AlphaProC and 
PGD-C2) incorporated with rOSFs and cultured for 7 and 14 d. Samples 
were washed with PBS and stored at −80 °C. Solubilization of collagen 
was achieved by breaking up the cell–gel constructs using acetic acid 
(0.05 m acetic acid) and transferring to a microcentrifuge tube, to which 
pepsin solution was added (0.1 mg mL−1). Collagen digestion took 
place at 4 °C for 24 h with gentle mixing on a rotor with occasional 
vigorous mixing by hand. Samples were then centrifuged (10 000 rpm, 
3 min) and supernatants collected and transferred into collection tubes. 
Supernatants were stored and analyzed to detect collagen type I as 
per manufacturers’ instructions using ELISA (product code: 6013, Rat, 
Chondrex, USA). Optical densities (ODs) of ELISA samples were read at 
490 nm using the BMG LABTECH plate reader.
Statistical Analysis: Means and standard deviations (SDs) were 
calculated from three repeats on each sample, except for alamarBlue 
quantification data, where triplicate readings were performed for each 
repeat. Error bars on graphs represent SD in both positive and negative 
orientation. Data were tested for normality and a one-way (Figure 2C) 
or two-way (Table 1, Figures 2D, 4B,C) analysis of variance (ANOVA)/
Kruskall–Wallis test was performed, followed by a Tukey’s posthoc test to 
determine the significance of origin for all data. Significance levels were 
defined as: *p < 0.05, **p < 0.01, and ***p < 0.001.
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